Short-Term Opioid Withdrawal Using Buprenorphine: Findings and Strategies from a NIDA Clinical Trials Network (CTN) Study

Overview

The Short-term Opioid Withdawal Using Buprenorphine (Bup Detox) Blending Team designed a training package to instruct treatment providers on the administration of aBup Detox Brochure Cover unique,13-day Buprenorphine taper intervention for opioid dependent patients. Research conducted in both inpatient and outpatient settings by the NIDA Clinical Trials Network demonstrated that, in contrast with the clonidine treatment group, patients receiving Buprenorphine provided more opioid-negative urine samples upon completion of the intervention. This training assumes some basic prior information about what Buprenorphine is and how it is used.

To obtain an overview of the Buprenorphine Treatment Blending product, download the brochure.

Blending Product Materials (download now!)

  • 4-hour classroom training providing instruction on using Buprenorphine for opioid dependent patients
  • PowerPoint presentation
  • Brochure
  • Research articles

Bup Detox Blending Team Members

NIDA/ NDAT CTN
Gregory Brigham, Ph.D. – Maryhaven Community Treatment Program
Judith Harrer, Ph.D. – VA Medical Center
Dennis McCarty, Ph.D. – Oregon Health and Science University

SAMHSA/CSAT-ATTC
Thomas Freese, Ph.D. – Pacific Southwest ATTC (Chair)
Beth Rutkowski, M.P.H. – Pacific Southwest ATTC
Kay Gresham-Morrison, LCSW, ACSW – Southeast ATTC
Susan Storti, Ph.D., RN – ATTC of New England

 

 

 

 

 

 

 

 

 

 

 

 

ATTC Network Home      Treatment & Help      The ATTC Hub        Contact Us      Site Map      Copyright Information      Join Our Email List
Site Developed by KC Web Programmers